Drug Shortage Report for COZAAR
| Report ID | 88869 |
| Drug Identification Number | 02182874 |
| Brand name | COZAAR |
| Common or Proper name | losartan potassium tablets |
| Company Name | ORGANON CANADA INC. |
| Market Status | MARKETED |
| Active Ingredient(s) | LOSARTAN POTASSIUM |
| Strength(s) | 50MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 30TAB |
| ATC code | C09CA |
| ATC description | ANGIOTENSIN II ANTAGONISTS, PLAIN |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2019-07-24 |
| Actual start date | 2019-07-11 |
| Estimated end date | 2019-10-08 |
| Actual end date | 2019-10-08 |
| Shortage status | Resolved |
| Updated date | 2019-10-09 |
| Company comments | Partial orders were released on Aug 20 |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 16766 ROUTE TRANSCANADIENNE KIRKLAND, QUEBEC CANADA H9H 4M7 |
| Company contact information | 1-844-820-5468 [email protected] |
Version History
Click on "Compare" below to view the full report history and compare to other versions.